Luigi Roberto Biasio

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Cross Sectional

Health Information

Respiratory Syndrome Coronavirus

Bacillus Subtilis

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Luigi Roberto Biasio, Chiara Lorini, Patrizio Zanobini, Guglielmo Bonaccorsi
The still unexplored mediating role of vaccine literacy. Human vaccines & immunotherapeutics 20 (1) (2024)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Guglielmo Bonaccorsi
Perspectives in the Development of Tools to Assess Vaccine Literacy. Vaccines 12 (4) (2024)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Guglielmo Bonaccorsi
Perspectives in the Development of Tools to Assess Vaccine Literacy. Vaccines 12 (4) (2024)
Luigi Roberto Biasio, Chiara Lorini, Patrizio Zanobini, Guglielmo Bonaccorsi
The still unexplored mediating role of vaccine literacy. Human vaccines & immunotherapeutics 20 (1) (2024)
Luigi Roberto Biasio, Chiara Lorini, Patrizio Zanobini, Guglielmo Bonaccorsi
The still unexplored mediating role of vaccine literacy. Human vaccines & immunotherapeutics 20 (1) (2024)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Pietro Monaci, Alice Fanfani, Veronica Gallinoro, Gabriele Cerini, Giuseppe Albora, Marco Del Riccio, Sergio Pecorelli, Guglielmo Bonaccorsi
COVID-19 vaccine literacy: A scoping review. Human vaccines & immunotherapeutics (2023)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Pietro Monaci, Alice Fanfani, Veronica Gallinoro, Gabriele Cerini, Giuseppe Albora, Marco Del Riccio, Sergio Pecorelli, Guglielmo Bonaccorsi
COVID-19 vaccine literacy: A scoping review. Human vaccines & immunotherapeutics 19 (1) (2023)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Pietro Monaci, Alice Fanfani, Veronica Gallinoro, Gabriele Cerini, Giuseppe Albora, Marco Del Riccio, Sergio Pecorelli, Guglielmo Bonaccorsi
COVID-19 vaccine literacy: A scoping review. Human vaccines & immunotherapeutics 19 (1) (2023)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Pietro Monaci, Alice Fanfani, Veronica Gallinoro, Gabriele Cerini, Giuseppe Albora, Marco Del Riccio, Sergio Pecorelli, Guglielmo Bonaccorsi
COVID-19 vaccine literacy: A scoping review. Human vaccines & immunotherapeutics 19 (1) (2023)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Pietro Monaci, Alice Fanfani, Veronica Gallinoro, Gabriele Cerini, Giuseppe Albora, Marco Del Riccio, Sergio Pecorelli, Guglielmo Bonaccorsi
COVID-19 vaccine literacy: A scoping review. Human vaccines & immunotherapeutics 19 (1) (2023)
Luigi Roberto Biasio, Patrizio Zanobini, Chiara Lorini, Pietro Monaci, Alice Fanfani, Veronica Gallinoro, Gabriele Cerini, Giuseppe Albora, Marco Del Riccio, Sergio Pecorelli, Guglielmo Bonaccorsi
COVID-19 vaccine literacy: A scoping review. Human vaccines & immunotherapeutics 19 (1) (2023)
Chiara Lorini, Francesca Collini, Giacomo Galletti, Francesca Ierardi, Silvia Forni, Claudia Gatteschi, Fabrizio Gemmi, Lorenzo Stacchini, Sophia Papini, Beatrice Velpini, Luigi Roberto Biasio, Guglielmo Bonaccorsi
Vaccine Literacy and Source of Information about Vaccination among Staff of Nursing Homes: A Cross-Sectional Survey Conducted in Tuscany (Italy). Vaccines 10 (5) (2022)
Luigi Roberto Biasio, Guglielmo Bonaccorsi, Chiara Lorini, Daniela Mazzini, Sergio Pecorelli
Italian Adults' Likelihood of Getting COVID-19 Vaccine: A Second Online Survey. Vaccines 9 (3) (2021)
Ugo Fedeli, Angelo Porreca, Michele Colicchia, Elena Schievano, Walter Artibani, Luigi Roberto Biasio, Giorgio Palù
Intravescical instillation of Calmette-Guérin bacillus and COVID-19 risk. Human vaccines & immunotherapeutics 17 (2) (2020)
Luigi Roberto Biasio, Guglielmo Bonaccorsi, Chiara Lorini, Sergio Pecorelli
Assessing COVID-19 vaccine literacy: a preliminary online survey. Human vaccines & immunotherapeutics 17 (5) (2020)
Luigi Roberto Biasio
Vaccine literacy is undervalued. Human vaccines & immunotherapeutics 15 (11) (2019)